Serbia to start producing Chinese Sinopharm vaccine

Doses of Sinopharm's China National Biotec Group COVID-19 vaccine during the vaccination at Belgrade Fair makeshift vaccination center in Belgrade, Serbia, 19 January 2021. [Andrej Cukic/EPA/EFE]

Serbia will become the first European country to produce the Chinese Sinopharm coronavirus vaccine, the Balkan country’s President Aleksandar Vučić said Thursday (11 March).

Vučić announced that a deal concerning the construction of a “vaccine factory” will be signed in the next two weeks, and it will be built with support of China and United Arab Emirates.

“We will start producing the vaccine as soon as 15 October”, Vučić told public broadcaster RTS after a meeting with the UAE’s de facto ruler Sheikh Mohammed bin Zayed al Nahyan in Abu Dhabi.

Although an EU-candidate country, Serbia has kept close diplomatic and economic ties with Moscow and Beijing, and has used the delicate balance to become continental Europe’s fastest vaccinator.

The small Balkan country has secured massive shipments of Sinopharm and Russia’s Sputnik V jab, leading the Balkan country to inoculate some 1.5 million of its 7 million population.

While the European Union kicked off its vaccination programme across its 27 member states late December, poor countries outside its borders in the Western Balkans have been left to fend for their own.

Vučić, in comments run by the RTS public broadcaster,

added that once the factory is set up, Serbia will provide the vaccine to countries throughout the region.

“What I learned tonight is that we will have to give the vaccine around the region, even at production cost”, Vučić said.

In February, Serbia was given preliminary approval to start manufacturing the Sputnik V vaccine as well, and has said production will begin in mid-May.

Subscribe to our newsletters